亚太地区水产养殖疫苗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按疫苗类型(活疫苗、灭活疫苗等)、品种(罗非鱼、鳟鱼、鲑鱼、虾等)、和给药途径(注射疫苗、浸泡疫苗和口服疫苗)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 135    |    Report Code: BMIRE00028088    |    Category: Life Sciences

Asia Pacific Aquaculture Vaccines Market

亚太水产养殖疫苗市场预计将从2022年的3305万美元增长到2028年的7498万美元。预计2022年至2028年复合年增长率为14.6%。

水产动物传染病患病率上升正在推动亚太水产养殖疫苗市场

根据国家医学图书馆 (NLM) 2022 年 2 月发表的题为“中国鱼类中异尖线虫的流行:系统回顾和荟萃分析”的研究报告,异尖线虫广泛存在全国鱼类中,合计发病率为45.5%,其中鲜鱼发病率最高(58.1%)。华东地区异尖线虫患病率最高(55.3%),其中东海地区异尖线虫患病率最高(76.8%)。根据《水产养殖研究与》发表的数据据发展杂志报道,2014年至2018年,鲜活水产养殖业共登记传染病病例约219例。其中,74.88%为寄生虫病,12.80%为细菌性病,1.83%为病毒性病,10.50%为寄生虫和细菌混合病。疾病。因此,传染病的高流行预计将增加对疫苗的需求,这将为未来几年的水产养殖疫苗市场提供利润丰厚的机会。

亚太水产养殖疫苗市场概况

亚太水产养殖疫苗市场细分为中国、日本、印度、韩国、澳大利亚和亚太其他地区。这些国家的市场增长归功于该地区水产养殖业的崛起和政府的有利举措。此外,市场参与者实施的扩张和产品推出策略预计将有助于该地区水产养殖疫苗市场的增长。作为主要消费市场,中国推动了对海鲜的巨大需求。鳟鱼和鲑鱼等一度被视为奢侈的物种现在已成为该国中产阶级消费者的负担。此外,根据斯德哥尔摩复原中心 2020 年的一份报告,到 2030 年,中国将成为海鲜过度消费国,将需要 6 至 18 吨海鲜才能满足消费者需求。这是由于海鲜消费水平快速增长,2020年中国消费者人均海鲜消费量将超过35公斤。根据中国工程院预测,2020年水产养殖总需求和产量将从8100万吨增长到1亿吨。 2035年。因此,中国水产养殖产品转向市场化、需求驱动型经济的战略、鱼病的增加以及人口对海鲜需求的增加将支持水产养殖疫苗市场的增长。 p>

 2028年亚太水产养殖疫苗市场收入及预测(百万美元)

< /strong>

亚太水产养殖疫苗市场细分

亚太水产养殖疫苗市场细分为疫苗类型、物种、给药途径和国家。

根据疫苗类型,亚太水产养殖疫苗市场细分为活疫苗、灭活疫苗、其他疫苗。 2022年,灭活疫苗市场份额最大。

按品种划分,亚太水产养殖疫苗市场分为罗非鱼、鳟鱼、鲑鱼、虾等。 2022 年,鲑鱼市场占据最大市场份额

根据亚太水产养殖疫苗市场的给药途径,分为注射疫苗、浸泡疫苗、和口服疫苗。 2022年注射疫苗市场占据最大份额。

按国家划分,亚太水产养殖疫苗市场分为澳大利亚、中国、印度、日本、韩国以及亚太其他地区。 2022 年,中国在水产养殖疫苗市场份额中占据主导地位。

Elanco Animal Health Inc;海普拉公司;默克公司有限公司; Phibro 动物保健公司;硕腾公司;印度免疫学有限公司;和 Nisseiken Co Ltd 是亚太水产养殖疫苗市场的领先公司。



Asia Pacific Aquaculture Vaccines Strategic Insights

Strategic insights for Asia Pacific Aquaculture Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacificaquaculture-vaccines-market-strategic-framework.webp
Get more information on this report

Asia Pacific Aquaculture Vaccines Report Scope

Report Attribute Details
Market size in 2022 US$ 33.05 Million
Market Size by 2028 US$ 74.98 Million
Global CAGR (2022 - 2028) 14.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 疫苗种类
  • 活疫苗
  • 灭活疫苗
By 种类
  • 罗非鱼
  • 鳟鱼
  • 鲑鱼
  • 虾
By 接种途径
  • 注射疫苗
  • 浸入疫苗
  • 口服疫苗
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Elanco Animal Health Inc
  • HIPRA SA
  • Merck & Co Inc.
  • Phibro Animal Health Corp
  • Zoetis Inc.
  • Indian Immunologicals Ltd
  • Nisseiken Co Ltd
  • Get more information on this report

    Asia Pacific Aquaculture Vaccines Regional Insights

    The regional scope of Asia Pacific Aquaculture Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacificaquaculture-vaccines-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Aquaculture Vaccines Market

    1. Elanco Animal Health Inc
    2. HIPRA SA
    3. Merck & Co Inc.
    4. Phibro Animal Health Corp
    5. Zoetis Inc.
    6. Indian Immunologicals Ltd
    7. Nisseiken Co Ltd
    Frequently Asked Questions
    How big is the Asia Pacific Aquaculture Vaccines Market?

    The Asia Pacific Aquaculture Vaccines Market is valued at US$ 33.05 Million in 2022, it is projected to reach US$ 74.98 Million by 2028.

    What is the CAGR for Asia Pacific Aquaculture Vaccines Market by (2022 - 2028)?

    As per our report Asia Pacific Aquaculture Vaccines Market, the market size is valued at US$ 33.05 Million in 2022, projecting it to reach US$ 74.98 Million by 2028. This translates to a CAGR of approximately 14.6% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Aquaculture Vaccines Market report typically cover these key segments-

  • 疫苗种类 (活疫苗, 灭活疫苗)
  • 种类 (罗非鱼, 鳟鱼, 鲑鱼, 虾)
  • 接种途径 (注射疫苗, 浸入疫苗, 口服疫苗)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Aquaculture Vaccines Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Aquaculture Vaccines Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Aquaculture Vaccines Market?

    The Asia Pacific Aquaculture Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Elanco Animal Health Inc
  • HIPRA SA
  • Merck & Co Inc.
  • Phibro Animal Health Corp
  • Zoetis Inc.
  • Indian Immunologicals Ltd
  • Nisseiken Co Ltd
  • Who should buy this report?

    The Asia Pacific Aquaculture Vaccines Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Aquaculture Vaccines Market value chain can benefit from the information contained in a comprehensive market report.